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Abstract
Objectives Nitrogen-containing bisphosphonates induce
osteonecrosis mostly in the jaw and less frequently in other
bones. Because of the crucial role of periosteal perfusion in
bone repair, we investigated zoledronate-induced microcircu-
latory reactions in the mandibular periosteum in comparison
with those in the tibia in a clinically relevant model of
bisphosphonate-induced medication-related osteonecrosis of
the jaw (MRONJ).
Materials and methods Sprague–Dawley rats were treated
with zoledronate (ZOL; 80 i.v. μg/kg/week over 8 weeks) or
saline vehicle. The first two right mandibular molar teeth were
extracted after 3 weeks. Various systemic and local
(periosteal) microcirculatory inflammatory parameters were
examined by intravital videomicroscopy after 9 weeks.
Results Gingival healing disorders (∼100 %) and MRONJ
developed in 70 % of ZOL-treated cases but not after saline
(shown by micro-CT). ZOL induced significantly higher de-
grees of periosteal leukocyte rolling and adhesion in the
mandibular postcapillary venules (at both extraction and intact
sites) than at the tibia. Leukocyte NADPH-oxidase activity
was reduced; leukocyte CD11b and plasma TNF-alpha levels
were unchanged.
Conclusion Chronic ZOL treatment causes a distinct micro-
circulatory inflammatory reaction in the mandibular perioste-
um but not in the tibia. The local reaction in the absence of
augmented systemic leukocyte inflammatory activity suggests
that topically different, endothelium-specific changes may
play a critical role in the pathogenesis of MRONJ.
Clinical relevance This model permits for the first time to
explore the microvascular processes in the mandibular peri-
osteum after chronic ZOL treatment. This approach may
contribute to a better understanding of the pathomechanism
and the development of strategies to counteract
bisphosphonate-induced side effects.
Keywords Mandibular periosteum . Intravital fluorescence
videomicroscopy . Leukocytes . Inflammation .
Bisphosphonate . Osteonecrosis
Introduction
Bisphosphonates (BISs) are widely used for the treatment of
osteoporosis and tumors with bone metastasis. The therapeu-
tic effect is linked to the inhibition of osteoclast activity, which
alters the bone metabolism by inhibiting bone resorption and
reducing the bone turnover [1]. Although BIS treatment un-
doubtedly improves the quality of life of the patients,
osteonecrosis is a serious adverse effect in a number of cases
[2]. BIS-related osteonecrosis of the jaw (recently termed as
Ágnes Janovszky and Andrea Szabó contributed equally to this work.
Á. Janovszky : R. Varga : J. Piffkó
Department of Oral andMaxillofacial Surgery, University of Szeged,
Szeged, Hungary
A. Szabó (*) :D. Garab :M. Boros : C. Mester :N. Beretka
Institute of Surgical Research, University of Szeged,
Szőkefalvi-Nagy Béla 6, Szeged H-6720, Hungary
e-mail: szabo.andrea.exp@med.u-szeged.hu
T. Zombori
Department of Pathology, University of Szeged, Szeged, Hungary
H.<P. Wiesmann :R. Bernhardt
Institute of Materials Science, Max Bergmann Center of
Biomaterials, TU Dresden, Dresden, Germany
I. Ocsovszki
Department of Biochemistry, University of Szeged, Szeged, Hungary
P. Balázs
Department of Image Processing and Computer Graphics, University
of Szeged, Szeged, Hungary
Clin Oral Invest (2015) 19:1279–1288
DOI 10.1007/s00784-014-1347-6
medication-related osteonecrosis of the jaw; MRONJ) occurs
mainly after invasive dental procedures, e.g., tooth extraction
[3], with an increased incidence particularly after the use of
third-generation BISs (e.g., zoledronate, ZOL) [1]. MRONJ
most probably has a multifactorial etiology and is influenced
by numerous factors, including the administration route and
dose, the duration of the therapy, the indication of BIS admin-
istration (osteoporosis or oncological reason), co-morbidities,
the concomitant use of other drugs (corticosteroids or chemo-
therapeutics), genetic factors, age, and poor oral hygiene [1,
3]. Local contamination and infection evoked by invasive
dental procedures in the presence of BIS treatment have also
been emphasized in the development of MRONJ [4].
Osteonecrosis, however, can develop several years later,
which may be explained by the long half-lives of these med-
ications [1] and not by the acute infectious induction. More-
over, BIS treatment has been shown to cause sterile inflam-
matory reactions such as aseptic peritonitis [5, 6] and an
enhancement of leukocyte–endothelial cell interactions in
the knee joint [7]. These effects may be linked to an upregu-
lation of pro-inflammatory cytokines such as IL-1 and TNF-
alpha [6–8] in response to BIS administration. The effects of
BISs also exhibit spatial differences, because certain inflam-
matory reactions are confined to the mandible and not present
in the femur [9]. Nevertheless, the exact pathomechanism of
MRONJ has not yet been clarified, and the possibilities of its
prevention or the use of curative modalities are also limited.
The periosteal perfusion significantly influences bone
healing and determines the prognosis of adjacent soft tissue
traumas as well [10]. Little, however, is known about the
microcirculatory effects of BIS and especially the microcircu-
lation of the mandible. Likewise, to date, no data are available
on the periosteal changes after invasive dental procedures
involving BIS treatment. In this study, we hypothesized that
a disturbed mandibular microcirculation may play a role in the
pathogenesis of MRONJ. With this background, we designed
an animal model ofMRONJ with the possibility of visualizing
the mandibular microcirculation by means of an intravital
videomicroscopy (IVM) technique. Our aims were to observe
and compare the mandibular and tibial periosteal microcircu-
latory reactions in rats subjected to chronic ZOL treatment
with or without tooth extraction.
Materials and methods
All chemicals were purchased from Sigma-Aldrich (St. Louis,
MO, USA) unless indicated otherwise. The study was per-
formed in accordance with the Guidelines laid down by the
National Institute of Health (NIH) in the USA regarding the
care and use of animals for experimental procedures and with
the 2010/63/EU Directive and was approved by the Animal
Welfare Committee of the University of Szeged (V/1639/
2013).
Experimental protocol
Twenty male Sprague–Dawley rats (average initial body
weight of 200±10 g) were randomly allocated to saline
vehicle-treated control (n=10) or intravenously (i.v.) ZOL-
treated (n=10, ZOL) groups. ZOL (zoledronic acid, Zometa,
Novartis Europharm, Budapest, Hungary) was administered
through the tail vein in a dose of 80 μg/kg once a week for
8 weeks. At the end of the 3rd week of the protocol, the first
and second molar teeth on the right side were extracted from
the mandible under ketamine and xylazine (i.p. 25 and
75 mg/kg, respectively) anesthesia. The teeth were luxated
with an 18G needle, and the extraction was performed with
extraction forceps. The roots were also removed with a dental
drill under a Zeiss operating microscope (×6 magnification;
Carl Zeiss GmbH, Jena, Germany). By thesemeans, the defect
was equal in size and severity in all rats. For pain relief,
intramuscular ketoprofen (Ketodex Forte; Berlin-Chemie
AG, Berlin, Germany; 5 mg/kg) and oral metamizole sodium
(Algopyrin; Sanofi-Aventis, Budapest, Hungary; 75 mg/kg)
were administered for 3 days. Mucosal healing processes were
monitored continuously throughout the experimental period.
Microcirculatory variables were examined on the 9th week
of the protocol. The animals were anesthetized intraperitone-
ally with an initial dose of sodium pentobarbital (45 mg/kg)
and placed in a supine position on a heating pad to maintain
the body temperature at 36–37 °C. Following cannulation of
the trachea, the penile vein was cannulated for the adminis-
tration of fluid and drugs (supplementary dose of sodium
pentobarbital; 5 mg/kg). This was followed by cannulation
of the femoral artery on the right side, and blood was drawn
for the white blood cell count and determination of the differ-
ent markers of leukocyte function/activation and inflamma-
tion (see later).
The mandibular periosteum was exposed for fluorescence
IVM on both sides, in the vicinity of the earlier extraction area
and on the contralateral side, between the anterior part of the
deep masseter and the anterior superficial masseter muscles,
as described elsewhere [11]. Briefly, an incision was made
parallel to the incisor tooth in the facial skin and the underly-
ing subcutaneous tissue, and the loose connective tissue be-
tween the fascia of the deep masseter and the anterior super-
ficial masseter muscles was carefully cut, using a microsurgi-
cal approach under an operating microscope (×6 magnifica-
tion; Carl Zeiss GmbH, Jena, Germany). By this means, the
periosteal membrane covering the corpus of the mandible at
the anterior margin of the molar region was reached, laterally/
distally to the incisor tooth. To aid better exposure for the
microscope objective, retraction was achieved by placing
1280 Clin Oral Invest (2015) 19:1279–1288
stitches with 7.0 monofilament polypropylene microsurgical
thread into the surrounding masseter muscles. For comparison
of the characteristics of the mandibular microcirculation with
those of the tibial periosteum, the medial/anterior surface of
the left tibia was exposed by complete transection of the
anterior gracilis muscle with microscissors and careful
atraumatic microsurgical removal of the connective tissue
covering the tibial periosteum [12]. After the IVM recordings
of the microcirculation, the animals were over-anesthetized
with a single overdose of pentobarbital, and the mandibles
were removed and placed into 10 % buffered formalin
solution for subsequent detection of osteonecrosis of the
mandible through micro-CT and histological analyses.
Fluorescence IVM
The exposed periosteal surfaces of the mandible (on
both the extracted and intact sides) and of the tibia
were consecutively examined by IVM. The exposed
surfaces were positioned horizontally on an adjustable
stage and superfused with 37 °C saline. The periosteal
microcirculation was visualized by IVM (penetration
depth: approx. 250 μm; Zeiss Axiotech Vario 100HD
microscope; 100-W HBO mercury lamp; Acroplan 20×/
0.5 N.A. W, Carl Zeiss GmbH, Jena, Germany). Fluo-
rescein isothiocyanate-labeled erythrocytes (0.2 ml i.v.)
were used to stain red blood cells and rhodamine-6G
(0.2 %, 0.1 ml i.v.) to stain leukocytes. Images from
four to five fields of the mandibular and the tibial
periosteum from each rat were recorded with a charge-
coupled device video camera (Teli CS8320Bi, Toshiba
Teli Corporation, Osaka, Japan) attached to an S-VHS
video recorder (Panasonic AG-MD 830; Matsushita
Electric Industrial Co., Tokyo, Japan) and a personal
computer.
Video analysis
Quantitative evaluation of the microcirculatory parameters
was performed off-line by the frame-to-frame analysis of the
videotaped images taken for IVM (IVM Software; Pictron
Ltd, Budapest, Hungary). Leukocyte–endothelial cell interac-
tions were analyzed in at least four postcapillary venules per
rat. Rolling leukocytes were defined as cells moving with a
velocity less than 40 % of that of the erythrocytes in the
centerline of the microvessel and passing through the ob-
served vessel segment within 30 s and are given as the number
of cells per second per vessel circumference. Adherent leuko-
cytes were defined as cells that did not move or detach from
the endothelial lining within an observation period of 30 s and
are given as the number of cells per square millimeter of
endothelial surface, calculated from the diameter and length
of the vessel segment. Red blood cell velocity (RBCV, μm/s)
was determined by frame-to-frame analysis of five to six
consecutive video-captured images taken after labeling of
the erythrocytes.
NADPH-oxidase activity of neutrophil leukocytes
The NADPH-oxidase activity of the isolated leukocytes
was determined by a modified chemiluminometric method
described by Bencsik et al. [13]. Blood was drawn from
the femoral artery into EDTA-containing tubes, and the
erythrocytes in 100 μl of whole blood were lyzed in a
hypotonic solution and centrifuged at 2000 g. The pellet
was resuspended and washed twice in a Dulbecco’s
phosphate-buffered saline solution. Twenty microliters of
resuspended pellet was incubated for 3 min at 37 °C in
Dulbecco’s solution containing lucigenin (1 mM), EGTA
(1 mM) and saccharose (140 mM). NADPH-oxidase ac-
tivity was determined via the NADPH-dependent increase
in luminescence elicited by adding 100 mM NADPH (in
20 μl), measured with an FB12 Single Tube Luminometer
(Berthold Detection Systems GmbH, Bad Wildbad, Ger-
many). Samples incubated in the presence of nitroblue
tetrazolium served as controls. The measurements were
performed in triplicates and were normalized for protein
content.
Whole blood free radical production
Ten microliters of blood dissolved in Hanks buffer was incu-
bated for 20 min at 37 °C in lucigenin (5 mM; dissolved in
Hanks buffer) or luminol (15 mM; dissolved in Hanks buffer)
solution in the presence or absence of zymozan (190 μM,
dissolved in Hanks buffer). Superoxide and hydrogen perox-
ide production were estimated via the zymozan-induced in-
crease in chemiluminescence (measured with the above
luminometer) and normalized for leukocyte counts in the
peripheral blood.
Expression of CD11b adhesion molecule on neutrophil
leukocytes
The surface expression of CD11b on the peripheral blood
granulocytes was determined by flow cytometric analysis as
detailed elsewhere [12], with a CyFlow ML (Partec GmbH,
Münster, Germany).
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Plasma TNF-alpha content
Blood samples were centrifuged at 13.500 rpm for 5 min at
4 °C and then stored at 70 °C until assayed. Plasma TNF-alpha
concentrations were determined in duplicate by means of a
commercially available ELISA kit (R&D Systems, Minneap-
olis, MN, USA).
Evaluation of the gingival lesions
Healing of the gingiva at the end of the study period (6 weeks
after the tooth extraction) was determined on the basis of an
osteonecrosis staging system provided by the American As-
sociation of Oral and Maxillofacial Surgeons [3]; this was
adapted for rats (see Table 1). The examination was performed
under an operating microscope (×6 magnification; Carl Zeiss
GmbH, Jena, Germany) by an independent maxillofacial sur-
geon. The incidence and the severity of the gingival healing
disorder were evaluated simultaneously.
Mandibular osteonecrosis as determined by micro-CT
Mandibles fixed with formaldehyde were used for micro-CT
imaging (SCANCO vivaCT 75; Scanco Medical, Brüttisellen,
Switzerland); subsequent analysis was performed on 2D sec-
tions in the coronal view of the images, the section being
chosen that showed the highest degree of tissue defect at the
earlier extraction site. The mean density of the bone was
estimated via the calculated percentage of the radiolucent area
of the alveolar portion of the bone.
Mandibular osteonecrosis as determined by histology
The specimens were fixed in 6 % neutral buffered formalin for
10 days, then rinsed in phosphate-buffered saline and
decalcified in 5 % EDTA for 7 days. The decalcified speci-
mens were embedded in paraffin and cut into 20 semi-serial
sections with a microtome (Shandon Finesse 325; Thermo
Scientific, Waltham, MA, USA), and routine hematoxylin
and eosin (H&E) staining was performed. The sections were
examined under a light microscope at ×4–40 magnification
(Model CHT; Olympus, Hamburg, Germany). The incidence
of osteonecrosis of the jaw was determined on the basis of
characteristic signs of necrosis, such as missing nuclear stain-
ing, the development of sequester formation and inflammato-
ry infiltration.
Statistical analysis
The statistical analysis was performed with a statistical
software package (SigmaStat for Windows; Jandel Sci-
entific, Erkrath, Germany). For the analysis of microcir-
culatory parameters, changes in variables within and
between groups (with respect to location and treatment,
separately) were analyzed by the two-way ANOVA test,
followed by the Holm–Sidak test. Differences between
groups (other inflammatory parameters and scores) were
analyzed with the Student t test. Data are presented as
mean values and SEM in all Figures and Tables. P
values <0.05 were considered significant.
Results
Microcirculatory inflammatory reactions
IVM recordings of the microcirculation were performed in a
mandibular periosteal region just adjacent to the site of the
Table 1 Scoring of macroscopic signs of the bisphosphonate-related
healing processes after tooth extraction (adopted from the staging of
MRONJ by Ruggiero et al. [3])
Score Exposed bone Inflammation/infection Fistula formation
Score 0 − − −
Score 1 + − −
Score 2 + + −
Score 3 + + +
Fig. 1 Periosteal primary leukocyte–endothelial cell interactions
(rolling) in saline- and ZOL-treated animals in the postcapillary venules
of the mandible on the tooth extraction (Ex) and the contralateral (C) sides
and in the tibia. Data are presented as means±SEM. Asterisk indicates
P<0.01 vs. the corresponding saline-treated group. The pound sign
indicates P<0.05 vs. the tibia. Two-way ANOVA was followed by the
Holm–Sidak test
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earlier tooth extraction and also on the contralateral side. Data
were compared with those on the tibial periosteum.
In vivo microscopy revealed homogenous microvas-
cular perfusion in all of the periosteal tissues examined;
the RBCVs were similar in the mandibular and tibial
capillary beds (827.5±30.1 μm/s and 739.0±37.7 μm/s,
respectively). The data were similar on the two sides of
the mandible and were not influenced by chronic ZOL
treatment (data not shown).
However, the leukocyte rolling in the postcapillary
venules of the mandible in the ZOL-treated group was
significantly higher than in the saline-treated group both
at the site of tooth extraction and on the contralateral
side; the differences between the sites were not statisti-
cally significant (Fig. 1). Similar differences were ob-
served in the leukocyte adhesion values after ZOL,
which revealed a statistically significant enhancement
in the mandibular periosteum as compared with the
tibial periosteum (Fig. 2). ZOL evoked similar rolling
and adhesion values irrespectively of the presence of
MRONJ (data not shown). The tibial microcirculation
was characterized by higher leukocyte rolling but simi-
lar adhesion in comparison with the data obtained for
the mandible in the saline-treated animals; none of them
were influenced by ZOL at this location.
Free radical production of leukocytes
The NADPH-oxidase activity of the neutrophil leuko-
cytes harvested from ZOL-treated animals was signifi-
cantly lower than that from the control animals
(Fig. 3a). The free radical-derived chemiluminescence
of the whole blood (as determined by the superoxide
and hydroxyl radical-dependent chemiluminescence mea-
surements) indicated no differences between the two
experimental groups (Fig. 3b).
Other inflammatory parameters
To exclude the possibility of increased leukocyte counts be-
hind the increased PMN rolling and adhesion after ZOL
treatment, the number of PMNs was determined with the
conventional Türk solution staining method and using a he-
mocytometer. As expected, the number of PMN leukocytes
was not higher (but rather even lower) in the rats chronically
treated with ZOL (Table 2).
As evidenced by the mean fluorescence values of the
adhesion molecule CD11b within the leukocyte population
(as measured by flow cytometry), no significant differences
were detected between the saline- and ZOL-treated animals
(Table 2).
There were no differences between the saline- and ZOL-
treated experimental groups with respect to the plasma TNF-
alpha levels either (n=6 and n=5, respectively) (Table 2).
Fig. 2 Periosteal secondary leukocyte–endothelial cell interactions
(sticking) in the postcapillary venules of the mandible on the tooth
extraction (Ex) and the contralateral (C) sides and in the tibia in saline-
and ZOL-treated animals. Data are presented as means±SEM. Asterisk
indicates P<0.01 vs. the corresponding saline-treated group. The pound
sign indicates P<0.01 vs. the tibia. Two-way ANOVAwas followed by
the Holm–Sidak test
Fig. 3 The effects of chronic
ZOL treatment on leukocyte
NADPH-oxidase activity (a) and
whole blood free radical
production (b) (the latter shown
by chemiluminescence in the
presence of lucigenin and luminol
to detect superoxide anion and
hydroxyl radical production,
respectively). Data are presented
as means±SEM. Asterisk
indicates P<0.05 vs. saline,
Student t- test
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Gingival healing after tooth extraction
Six weeks after the tooth extraction, intact mucosa could be
observed in 8/10 of the control animals (the average healing
score was 0.25±0.25), but different degrees of mucosal
healing disorders were detected in all (10/10) of the ZOL-
treated animals. The severity of the healing disorders reached
a score of 1.83±0.18 in this group (p<0.01).
Incidence and severity of mandibular osteonecrosis
Normal bony regeneration with a radiolucent areas of 12.09±
1.91 % of the alveolar bone could be detected at the site of the
earlier tooth extraction in all (10/10) of the saline-treated
animals. In contrast, a certain degree of discontinuity of the
cortical and spongious bone regions was found in 7/10 of the
ZOL-treated animals (Fig. 4). This higher incidence of im-
paired bony regeneration was accompanied by a significantly
lower average bone density in this group (39.51±7.18 % of
the alveolar area) as compared with that in the saline-treated
group (p<0.01).
The radiological diagnosis of mandibular osteonecrosis
was confirmed by standard histological examinations
(Fig. 5). Findings of missing nuclear staining in the osteocytes
increased inflammatory infiltration and granulation tissue for-
mation around the necrotic area, and occasional sequester
formation were made in 6/10 of the ZOL-treated animals,
whereas nearly normal bone regeneration was observed in
the other rats.
Discussion
The major aim of the present study was to examine the
mandibular periosteal microcirculatory reactions in a ro-
dent model of MRONJ. Through the chronic administra-
tion of high i.v. doses of ZOL in combination with an
invasive dental intervention, a high prevalence of mucosal
healing disorders (∼100 %) was achieved together with a
relatively high osteonecrosis rate (70 %; as revealed by
micro-CT and histological analyses). This protocol was
based on a modified literature method [14]. BIS doses in
the range 20–2250 μg/kg with different frequencies and
different administration routes have been administered by
others (for a meta-analysis [15]). The relatively high dose
applied here (80 μg/kg/week) is still well tolerated in rats,
and although it was also administered in a higher frequen-
cy than on human use, it produced symptoms and radio-
logical evidence similar to those observed in humans.
Apart from the dose of ZOL, the relatively high incidence
of MRONJ in this study can be explained by (1) the
triggering effect of the applied dental extraction (the
Table 2 The effects of chronic ZOL treatment on the leukocyte count,
neutrophil-derived CD11b adhesion molecule expression and plasma
TNF-alpha levels
Parameter Saline ZOL P values





1.57±0.21 1.37±0.09 n. s.
TNF-alpha (pg/ml) 2.65±0.49 2.33±0.39 n. s.
Data are presented as mean±SEM. P<0.05 vs. saline, Student t test
n. s. not significant
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Fig. 4 Bone density differences expressed as a percentage of the radio-
lucent area of the alveolar bone (marked with a rectangle) in saline- and
BIS-treated animals 6 weeks after tooth extraction (a). Data are presented
as means±SEM. Asterisk indicates P<0.05 vs. saline, Student t test.
Micro-CT scans show representative images of the mandibular cross-
sections in saline- and ZOL-treated rats (b and c, respectively)
importance of which has been demonstrated in MRONJ
patients) [3]) and (2) the use of the mandibular site (there
is a higher prevalence of osteonecrosis at this localization
in humans) [16].
It is reasonable to assume that impaired regeneration pro-
cesses contribute to the pathophysiology of MRONJ. From a
functional aspect, bony regeneration processes depend not
only on the functional activity of the osteoblasts and
osteoclasts but also on the blood supply and angiogenesis.
BISs have been shown to influence all of these processes. As
such, the inhibition of osteoclast recruitment to the bone
surface [17] and shortening of the osteoclast life span are the
main effects of BISs that are brought about directly or indi-
rectly (via the OPG-RANKL pathway) [18]. Accordingly,
delayed bone healing [19, 20], together with decreased bone
formation and vascularity in the extraction socket, have been
detected in ZOL-treated rats [21]. Numerous studies have
elucidated the antiangiogenic effects of BIS both in vitro
[22] and in vivo [20, 23]. Furthermore, thicker and less
connected/ordered blood vessels in the alveolar bone of the
mandible were found in ZOL-treated rats after tooth extraction
[24]. The aim of the present study was to assess not the
structural but the functional aspects of chronic BIS treatment
on the microvasculature.
Direct toxic and inflammatory effects of BISs may also
contribute to the development of MRONJ. BISs exert toxic
effects on many different cell types (fibroblasts, osteoblasts,
and endothelial and epithelial cells), manifested in diminished
cell proliferation and decreased collagen production, ZOL
being the most inhibitory in this respect [25–27]. Furthermore,
marked inflammatory reactions are attributed to BISs through
the induction of peritonitis via the activation of immunologi-
cal pathways after intraperitoneal administration [5, 6, 28].
Enhanced leukocyte–endothelial interactions have been dem-
onstrated by means of IVM after BIS treatment in an arthritis
model in mice [7]. BIS-associated inflammatory bony chang-
es have also been detected in the mandible [9, 29]. Interest-
ingly, these inflammatory changes were limited to the mandi-
ble and were not seen in the femur or the tibia [9, 29]. High-
dose ZOL exacerbates the inflammatory response in a peri-
odontitis model, where the bone lesions strikingly resemble
MRONJ [21]. In the present study, pro-inflammatory aspects
of chronic BIS treatment could also be traced in the mandib-
ular periosteum, and histological analysis supported the infil-
tration of the tissue by leukocytes in the neighboring necrotic
zone.
In this microsurgical model, the periosteal microcirculation
of the mandible can be visualized relatively easily in the molar
region, which is likewise a cardinal localization of MRONJ
[3]. Apart from nutritive considerations, the periosteum is
important for its osteoprogenitor cell content during bone
regeneration. Although BISs exert effects on osteoblast pro-
liferation, differentiation and migration in the entire skeleton
[30], their action seems to depend on the anatomical location,
with the jawbones as highly frequent sites of osteonecrosis.
After prolonged use, BISs are known to accumulate in the
skeleton, reaching the highest concentration in the mandible
[25, 31], which may explain their potential toxic effects pre-
dominantly in the jawbones. Furthermore, osteoblasts have
different proliferation properties at different locations (appen-
dicular vs. axial bones) under physiological circumstances,
Fig. 5 Representative micrograph (H&E staining) showing regeneration
processes in a ZOL-treated animal 6 weeks after tooth extraction (mag-
nification ×4) (a). s salivary gland, m muscle, b bone, g gingiva, ct
connective tissue. Sequester formation (se) and lack of nuclear staining
of the necrotic bone (nb) and PMN granulocyte infiltration around the
necrotic area (center of the section) can be seen at higher magnifications
(magnifications ×10 and 40) (b, and c, respectively). The bar denotes
200 μm
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and this phenomenon is also critically influenced by BIS
treatment [32]. The functional activity of the osteocytes too
differs between the mandible and the tibia [33], and the
aggravating effects of BISs on bone healing are confined to
the jaw [34]. Although the above findings reveal certain
potential factors contributing to the higher incidence of
osteonecrosis of the jawbones, the exact pathomechanism is
unknown.
As opposed to the microcirculatory consequences of bone
injury (i.e. fractures) [35], the effects of tooth extraction on the
microcirculatory derangement and local inflammation are less
commonly described, due to methodological constraints. We
focus here on the microcirculatory aspects of chronic ZOL
treatment combined with an earlier local trauma of the jaw
(tooth extraction). IVM data were obtained in the proximity of
the injury and from a contralateral (intact) site on the mandib-
ular periosteum and were compared with those relating to the
intact tibia. After chronic ZOL treatment, increased degrees of
leukocyte–endothelial interactions (rolling and adhesion)
were observed in the mandibular periosteum, both at the site
of the earlier tooth extraction and at the contralateral site, but
the corresponding interactions in the tibia were less extensive.
It is still an unanswered question why the examined cell-to-
cell interactions are higher in the postcapillary venules of the
mandible, irrespectively of the proximity of the tooth extrac-
tion site and the presence of MRONJ in the ZOL-treated
group. In preliminary studies, we did not observe inflamma-
tory complications in the mandibular periosteum without
tooth extraction, which demonstrated the triggering effect of
the trauma in this region. This observation was supported by
further findings, when more intense inflammatory reactions of
ZOL were evolved in the acute phase after tooth extraction
(data not shown). The inflammatory processes were similarly
shown in an IVM study to be aggravated by a BIS in an
arthritis model in mice [7]. Elevated levels of the pro-
inflammatory cytokine TNF-alpha have been reported in hu-
man patients in response to certain types of BISs [8] but were
not detected after the chronic administration of a BIS in our
study. Furthermore, the number and functional activity (free
radical-producing capacity) of PMNs were moderately re-
duced here. Such effects on the free radical-producing poten-
tial of PMNs (including NADPH-oxidase activity) have also
been demonstrated by others [36, 37]. Favot et al. suggested
that the compromised neutrophil functions, too, may be used
as potential biomarkers for MRONJ susceptibility [38]. Inter-
estingly, others have found impaired neutrophil chemotaxis
after BIS exposure in mice [36] and humans [38], and this
parameter is influenced most extensively by ZOL among the
different types of BISs [39]. For leukocyte–endothelial inter-
actions (as seen in our study), an enhanced expression of
adhesion molecules is required on the surface of the endothe-
lial cells and/or neutrophil leukocytes [40]. Interestingly, ex-
pression of the neutrophil-derived adhesion molecule CD11b
(responsible for leukocyte adherence) was not found to be
influenced by chronic ZOL treatment here or in other studies.
The extents of these inflammatory reactions, however, dif-
fered in the jaw and the tibial regions. These regional differ-
ences might be explained by different degrees of endothelium-
derived adhesion molecule expression at the different anatom-
ical locations.
Conclusions
A causative relationship between the microcirculatory inflam-
matory reactions and the pathogenesis of MRONJ could not
be provided in the present study; regional differences in en-
dothelial function/dysfunction, however, may contribute to
the explanation of differences in the occurrence of
osteonecrosis seen at different anatomical locations.
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